We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » European Drugmakers Push for More Clarity on Early Meetings with EMA, Drug Payers
European Drugmakers Push for More Clarity on Early Meetings with EMA, Drug Payers
A trio of European pharmaceutical trade groups is seeking greater clarity around the European Medicines Agency’s initiative to streamline the drug approval process through parallel reviews for both reimbursement and safety and efficacy.